DSM Biologics and AC Immune SA have signed a Memorandum of Understanding in which the parties have agreed that DSM will be the development and manufacturing partner for AC Immune’s monoclonal antibody against Alzheimer’s disease. The development and manufacturing activities will be done in DSM Biologics’ FDA-approved manufacturing facility in Groningen, The Netherlands. AC Immune is based in Lausanne, Switzerland. “After an intensive market analysis we have decided to choose DSM as our partn...